Thank you, Mr. Chair. Thank you everyone. This is very enlightening.
My question is for Ms. Gibeau.
I took a look at the conclusion of your document. I saw that there were many topics you would like to talk about, but you couldn't. So I'd like to give you the opportunity to speak about one of them.
You already got ahead of me in one of your other answers. In your document, you mentioned "other areas where the government could make cuts". You go on to say:
For example, it might … cut the subsidies granted to pharmaceutical companies now that it has been shown that for several years that industry has not honoured its promises to reinvest 10% of its profits in R&D.
First, I'd like you to speak to us about this. Then I'd like you to continue with the possible reduction of drug costs.